BUDILITE L RESPULE

Product Description

BUDILITE L RESPULE is a clinically formulated combination of Budesonide and Levosalbutamol, designed to provide fast and effective relief for patients suffering from chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This dual-action respule offers both anti-inflammatory and bronchodilatory effects, making it a preferred choice among pulmonologists and healthcare providers.

Key Benefits:

• Dual Mechanism of Action: Combines Budesonide, a corticosteroid that reduces airway inflammation, with Levosalbutamol, a beta-2 agonist that provides rapid bronchodilation.

• Effective Symptom Relief: Controls wheezing, shortness of breath, chest tightness, and other obstructive respiratory symptoms.

• Inhalation-Based Delivery: Directly targets the lungs for quick onset of action and minimal systemic side effects.

• Ideal for Maintenance & Rescue Therapy: Suitable for long-term asthma management and acute exacerbation episodes.

• Sterile & Ready-to-Use: Single-dose respule format ensures hygiene, convenience, and consistent dosage.

Recommended For:

• Hospitals and respiratory care clinics

• Wholesale pharmaceutical distributors

• Pharmacies and medical retailers

• Government and private healthcare procurement

• Exporters and institutional bulk buyers

Usage & Administration:

Administer via a nebulizer as prescribed by a healthcare professional. Dosage may vary depending on patient condition and physicians direction. Not intended for use in children without medical supervision.

Compliance & Standards:

• Manufactured under strict GMP conditions

• Compliant with Indian Pharmacopoeia (IP) standards

• Suitable for domestic and export markets